Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
Dragana Savic, Leanne Hodson, Stefan Neubauer, et al.
Nutrients (2020) Vol. 12, Iss. 8, pp. 2178-2178
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 174-174
Open Access | Times Cited: 344
The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation
Ashraf Virmani, Maria Cirulli
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2717-2717
Open Access | Times Cited: 136
Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress
Alimire Abulikemu, Xinying Zhao, Hailin Xu, et al.
Redox Biology (2022) Vol. 59, pp. 102569-102569
Open Access | Times Cited: 71
l-carnitine: Nutrition, pathology, and health benefits
Abdulaziz Hassan Alhasaniah
Saudi Journal of Biological Sciences (2022) Vol. 30, Iss. 2, pp. 103555-103555
Open Access | Times Cited: 46
Dietary supplementation with casein/cyanidin-3-O-glucoside nanoparticles alters the gut microbiota in high-fat fed C57BL/6 mice
Qiyan Lyu, Hongting Deng, Shunxin Wang, et al.
Food Chemistry (2023) Vol. 412, pp. 135494-135494
Closed Access | Times Cited: 30
Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
Na Li, Hui Zhao
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
The effects of L-carnitine supplementation on inflammatory and anti-inflammatory markers in adults: a systematic review and dose–response meta-analysis
Samira Rastgoo, Sahand Tehrani Fateh, Mahlagha Nikbaf‐Shandiz, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2173-2199
Closed Access | Times Cited: 17
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe
Molecules (2024) Vol. 29, Iss. 3, pp. 709-709
Open Access | Times Cited: 5
Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength
Dana Crișan, Lucreţia Avram, Andreea Morariu-Barb, et al.
Nutrients (2025) Vol. 17, Iss. 1, pp. 178-178
Open Access
Ancestral bisphenol A exposure led to nonalcoholic fatty liver disease and sex-specific alterations in proline and bile metabolism pathways in the liver
Sourav Chakraborty, Santosh Anand, Muhammad Numan, et al.
Environmental Toxicology and Chemistry (2025)
Closed Access
Pharmaceutical technological trends containing flavonoids: a patent review
Ana Maria Santos Oliveira, Anamaria Mendonça Santos, José Adão Carvalho Nascimento Júnior, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 363-379
Closed Access
CE–MS Metabolomic and LC–MS Proteomic Analyses of Breast Cancer Exosomes Reveal Alterations in Purine and Carnitine Metabolism
Emil Zaripov, Abdullah Khraibah, Petr Kasyanchyk, et al.
Journal of Proteome Research (2025)
Closed Access
Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
Feng Xiang, Zhimin Zhang, Jingchen Xie, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Changes in the lipidome of Tibetan pork during refrigeration
Yuru Shui, Wanlin Cai, Xuedong Gu, et al.
Applied Food Research (2025), pp. 100846-100846
Open Access
Phase-dependent hepatotoxicity of Aluminum oxide nanoparticles mediated through the intestinal microbiota
Mingshu Li, Fuchang Deng, Li Dong, et al.
Environment International (2025), pp. 109398-109398
Open Access
A novel chicken model of fatty liver disease induced by high cholesterol and low choline diets
Chiao-Wei Lin, Ting-Wei Huang, Yu-Ju Peng, et al.
Poultry Science (2020) Vol. 100, Iss. 3, pp. 100869-100869
Open Access | Times Cited: 41
Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
Qiongbo Wu, Zihao Chen, Yi Ding, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 22
Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment
Jiayuan Zhang, Xiaoling Zang, Jinxiao Lv, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1502-1502
Open Access | Times Cited: 15
Comparative Determination of Mitochondrial Biomarkers and Their Relationship With Insulin Resistance in Type 2 Diabetic Patients: An Observational Cross‐Sectional Study
Emmanuel Ofori, Wormenor Dziedzorm, Alfred Buabeng, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 4
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
Müjdat Zeybel, Özlem Altay, Muhammad Arif, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 10
Open Access | Times Cited: 29
SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites
X Q Li, Yimeng Du, Chunyuan Xue, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8970-8970
Open Access | Times Cited: 10
Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
Joel Yeh Siang Chen, Damien Chua, Carissa Odelia Lim, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 158-158
Open Access | Times Cited: 15
DNA hydroxymethylation reprogramming of β-oxidation genes mediates early-life arsenic-evoked hepatic lipid accumulation in adult mice
Yaping Song, Jin-Wei Lv, Ying Zhao, et al.
Journal of Hazardous Materials (2022) Vol. 430, pp. 128511-128511
Closed Access | Times Cited: 14
Serum Metabolomics Uncovers the Mechanisms of Inulin in Preventing Non-Alcoholic Fatty Liver Disease
Yunhong Sun, Wenjun Zhou, M.A. Zhiliang Zhu
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 895-895
Open Access | Times Cited: 2
Metabolic Signature of Ethanol-Induced Hepatotoxicity in HepaRG Cells by Liquid Chromatography–Mass Spectrometry-Based Untargeted Metabolomics
Elias Iturrospe, Katyeny Manuela da Silva, Rani Robeyns, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 4, pp. 1153-1166
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top